Article Text
Statistics from Altmetric.com
Report by Mark Davies, Senior Clinical Fellow Search checked by Angaj Ghosh, Senior Clinical Fellow
Clinical scenario
You see a 50 year old man with a two hour history of cardiac chest pain and an ECG suggestive of acute myocardial infarction. You decide to thrombolyse. The cardiology registrar suggests that you also give intravenous magnesium to reduce the incidence of ventricular fibrillation. You wonder whether there is any evidence to support this.
Three part question
In [patients with suspected acute myocardial infarction] is [magnesium] effective at [reducing the incidence of ventricular fibrillation].
Search strategy
Medline 1966–11/00 using the OVID interface. [(exp myocardial infarction OR myocardial infarction.mp OR MI.mp) AND (exp magnesium sulfate OR magnesium sulfate.mp OR magnesium sulphate.mp OR exp magnesium OR exp magnesium.mp OR exp magnesium chloride OR magnesium chloride.mp) AND (exp arrhythmia OR arrhythmia.mp OR dysrhythmias.mp OR exp ventricular fibrillation OR ventricular fibrillation.mp OR (VF.mp) or (exp. mortality/ or mortality.mp)] AND maximally sensitive RCT filter LIMIT to human AND english.
Search outcome
Altogether 103 papers found of which 86 were irrelevant and 12 of insufficient quality for inclusion. The remaining five papers are shown in table 5.
Comments
A number of small studies published have suggested that magnesium therapy significantly improves mortality following myocardial infarction. While the two larger studies show a trend to reduction in the incidence of ventricular fibrillation but also demonstrates that this benefit is outweighed by an increased incidence of detrimental effects.
Clinical bottom line
Routine prophylactic magnesium in patients with myocardial infarction is not indicated.
Report by Mark Davies, Senior Clinical Fellow Search checked by Angaj Ghosh, Senior Clinical Fellow